Week in Review: Unnamed China Pharma Buys Bayer AG's Vacated Bay-Area Campus

by Richard Daverman, PhD

December 29, 2012 -- A major, though still unnamed, China biopharma bought a prestigious San Francisco-area biotech campus (it formerly belonged to Bayer) and will disclose its plans for the site next month; HitGen and Viva Biotech, two China CROs specializing in early-stage services, will partner up to provide an early-stage hit-to-lead-generation program; Naton Medical, a Beijing maker of orthopedic products, joined with two Malaysia-based medical device companies, OSA Niaga and Straits Orthopedics, to form a Malaysian JV; and India will locate its own drug inspection office in China in March of 2013, complete with four full-time inspectors. More details….

Stock Symbol: (Xetra: BAY)